Chemokine receptor engineering (CXCR1, CXCR4, CCR7) improves trafficking and tumor infiltration both in hematological and solid tumors (Ng et al., 2019; Andreou et al., 2025). This evidence concerns the gene CXCR1 and neoplasm.